Figure 4From: Distinct serum metabolomics profiles associated with malignant progression in the KrasG12Dmouse model of pancreatic ductal adenocarcinomaPrediction analysis based on the generation of an early or late metabolic signature. Early metabolic signatures were able to distinguish controls from diseased animals at the late stage. Supporting this, a signature from the late stage animals was able to identify animals with or without early lesions.Back to article page